Vogreen Medicinal Housefly Larvae Clinical Case Summary (Non-Hodgkin Lymphoma with Multiple Metastases)
Vogreen Clinical Data CenterReleased 2024About 8 min read
Key Data Overview
CR
Clinical Remission
Complete remission
Metastases/effusions resolved
Normal
PET-CT Metabolism
Returned to work
Improved chemo tolerance
Case Summary
A 46-year-old male with Non-Hodgkin lymphoma (DLBCL stage IV-b) and multiple metastases received rituximab chemo combined with Vogreen for 18 months. Follow-up showed complete disappearance of metastases and effusions, normal PET-CT FDG metabolism, and he returned to work. Vogreen reduces chemo toxicity and improves tolerance. For reference only, not medical advice.
Key Data & Reports
Please refer to the medical reports and data charts below for detailed examination results and imaging records.
Medical Reports & Data
Non-Hodgkin lymphoma PET/CT re-examination — normal lymph node FDG metabolism
Disclaimer: This page documents a real-world adjuvant care case of Vogreen Medicinal Housefly Larvae for academic exchange only. It does not constitute medical advice and cannot replace standard anti-tumor treatments such as surgery, radiotherapy or chemotherapy. Individual results vary. Please follow your physician's guidance.